scholarly journals Value of ultrasonography in the diagnosis of primary hepatic carcinoma and thyroid carcinoma

2018 ◽  
Author(s):  
Lei Wang ◽  
Xiaojie Pan ◽  
Jianbing Qin
Keyword(s):  
Thyroid Carcinoma ◽  
Hepatic Carcinoma ◽  
Primary Hepatic Carcinoma

scholarly journals Efficacy and Safety of Aidi Injection Combined with Transcatheter Arterial Chemoembolization on Primary Hepatic Carcinoma: A Systematic Review and Meta-Analysis

2018 ◽  
Vol 2018 ◽  
pp. 1-14
Author(s):  
Weihao Chen ◽  
Yurong Wang ◽  
Qiuer Liang ◽  
Yunfei Cai ◽  
Xudong Chen ◽  
...  
Keyword(s):  
Clinical Response ◽  
Transcatheter Arterial Chemoembolization ◽  
Response Rate ◽  
Clinical Response Rate ◽  
Efficacy And Safety ◽  
Hepatic Carcinoma ◽  
Primary Hepatic Carcinoma ◽  
Significant Difference ◽  
Aidi Injection ◽  
Arterial Chemoembolization

Objectives. To evaluate the efficacy and safety of Aidi injection (ADI) combined with transcatheter arterial chemoembolization (TACE) for primary hepatic carcinoma (PHCC). Methods. We conducted a literature search in EMBASE, PubMed, CENTRAL, MEDLINE, CNKI, Wanfang, and VIP databases from the earliest possible year to April 2018. Randomized controlled trials (RCTs) involving ADI combined with TACE versus TACE alone for patients with PHCC were included. The Cochrane Risk of Bias tool was applied for quality assessment. Results. 22 studies involving 1611 participants were included. The clinical response rate (RR = 1.28, 95% CI: 1.17-1.40; P < 0.00001), KPS score (RR = 1.78, 95% CI: 1.59-2.00; P < 0.00001), survival rate (RR = 1.27, 95% CI: 1.16-1.39; P < 0.00001), immune function (MD = 1.24, 95% CI: 0.98-1.51; P < 0.00001), and adverse effects (RR = 0.62, 95% CI: 0.57-0.68; P < 0.00001) of ADI plus TACE showed significant difference when compared with TACE alone. Conclusions. ADI combined with TACE in the treatment of PHCC improved the clinical response rate and safety compared to TACE alone. However, due to poor methodological quality of many of the included RCTs, more rigorously designed and large-scale RCTs are warranted to examine this beneficial effect in the future.

scholarly journals Effect of iodized oil embolization on ablation rates in primary hepatic carcinoma

2015 ◽  
Vol 23 (36) ◽  
pp. 5859
Author(s):  
Xing-Wei Sun ◽  
Yong Jin ◽  
Xu-Ming Bai ◽  
Long Cheng ◽  
Xing-Shi Gu ◽  
...  
Keyword(s):  
Hepatic Carcinoma ◽  
Iodized Oil ◽  
Primary Hepatic Carcinoma

scholarly journals The relationship between serum hepatitis B core-related antigen and hepatitis B virus DNA in treatment-naïve patients with hepatitis B cirrhosis: A cross-sectional study

2021 ◽  
Author(s):  
Baiguo Xu ◽  
Lian Jia ◽  
Anjing Liu ◽  
Ying Liu ◽  
Tao Han ◽  
...  
Keyword(s):  
Family History ◽  
Hepatitis B ◽  
Hbv Dna ◽  
Hepatic Carcinoma ◽  
Primary Hepatic Carcinoma ◽  
B Virus ◽  
Treatment Naïve ◽  
History Of ◽  
Pugh Class ◽  
The Relationship

Abstract Aims. The relationship between hepatitis B core-related antigen (HBcrAg) and hepatitis B virus (HBV) DNA has already been adequately researched in patients with chronic hepatitis B (CHB) infection, but there are only a few researches yet on the correlations between HBcrAg and HBV DNA in treatment-naïve patients with hepatitis B cirrhosis. Here we explore the correlation between HBcrAg and HBV DNA in this population. Methods. Available data and samples of 98 untreated patients with hepatitis B cirrhosis between October 2018 and October 2019 were analysed. Statistical analyses included baseline characteristics, univariate analysis, stratification analysis, three different analytical models, and a generalized additive model. Results. After adjusting for all recorded confounders (sex, age, diagnosis of primary hepatic carcinoma, total bilirubin（TBIL）, hepatitis B surface antigen (HBsAg), hepatitis B e antigen(HBeAg), Child–Pugh class, family history of HBV infection, family history of hepatocellular carcinoma(HCC), alcohol-related liver disease (ALD), and diabetes mellitus), a linear relationship was detected between HBcrAg and HBV DNA (β=0.59, 95%CI=0.34–0.84, P<0.0001). The variational trend of HBcrAg and HBV DNA in each stratified variable (sex, age, HBeAg, family history of HBV infection, family history of HCC, diabetes mellitus, diagnosis of primary hepatic carcinoma, Child–Pugh class, and ALD) were consistent. Conclusion. There was a linear and positive correlation between HBcrAg and HBV DNA in treatment-naïve patients with hepatitis B cirrhosis.

scholarly journals Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic Carcinoma

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Xin’ai Wu ◽  
Jianbo Li ◽  
Cheng Wang ◽  
Guojian Zhang ◽  
Na Zheng ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Early Stage ◽  
Survival Rates ◽  
Hepatic Carcinoma ◽  
Imaging Methods ◽  
Positron Emission ◽  
Ultrasound Computed Tomography ◽  
Primary Hepatic Carcinoma ◽  
The Common ◽  
The One

Primary hepatic carcinoma (PHC) is the one of the most common tumors and the common cause of cancer death in the world. Detecting PHC in its early stage by imaging methods may greatly increase survival rates of patients. Ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography/computed tomography are common imaging methods in the diagnosis of PHC. In this paper, the application of different imaging methods in diagnosing the primary hepatic carcinoma will be discussed.

Ultrastructure of human primary hepatic carcinoma

Cancer ◽  
1966 ◽  
Vol 19 (11) ◽  
pp. 1594-1606 ◽  
Author(s):  
Cyril Toker ◽  
Norberto Trevino
Keyword(s):  
Hepatic Carcinoma ◽  
Primary Hepatic Carcinoma
Sign in / Sign up

Export Citation Format

Share Document